USPTO serial 86655356
THERAPURE BIOLOGICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LAMONT, MIAH ROSENBERG
- Law office
- LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with THERAPURE BIOLOGICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mississauga, Ontario, CA
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations in the nature of biologics, biopharmaceuticals, and drugs, all derived from human blood, human plasma, cryopaste, and cryoprecipitate for human clinical use, to treat acute and chronic medical conditions; pharmaceutical preparations in the nature of biologics, biopharmaceuticals, drugs derived from human blood, human plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins | ACTIVE | — |
| 040 | Manufacturing services for others in the field of biologics, namely, contract manufacturing and/or toll manufacturing of plasma derived biologics from human blood, human plasma, cryopaste, and cryoprecipitate for research and development and clinical use; consulting in the field of manufacturing practices and facilities for pharmaceutical preparations related to biologics derived from human blood, human plasma, cryopaste, and cryoprecipitate for human clinical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 1, 2020 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 1, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 13, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 13, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 13, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 4, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 4, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2019 | ALIE | ASSIGNED TO LIE | — |
| Aug 22, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 4, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Mar 4, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Mar 4, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Mar 4, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 28, 2019 | ALIE | ASSIGNED TO LIE | — |
| Aug 8, 2018 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 7, 2018 | ALIE | ASSIGNED TO LIE | — |
| Feb 6, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 6, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 6, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 6, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 6, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 31, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 23, 2017 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Aug 23, 2017 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Aug 23, 2017 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Aug 22, 2017 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 16, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 16, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 16, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 16, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 16, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 9, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 12, 2016 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Aug 12, 2016 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Aug 12, 2016 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Aug 11, 2016 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 5, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 5, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 5, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 27, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 27, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 24, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 4, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 3, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 30, 2015 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jun 25, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jun 17, 2015 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 12, 2015 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 11, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2015 | NWAP | NEW APPLICATION ENTERED | — |